Literature DB >> 3490496

Actions of growth factors on plasma calcium. Epidermal growth factor and human transforming growth factor-alpha cause elevation of plasma calcium in mice.

A H Tashjian, E F Voelkel, W Lloyd, R Derynck, M E Winkler, L Levine.   

Abstract

Specific humoral substances produced and secreted by human tumors that cause hypercalcemia have not been identified. Certain growth factors (such as epidermal growth factor, platelet-derived growth factor, and transforming growth factors-alpha and -beta) have been shown to stimulate the resorption of bone in organ culture by both prostaglandin-dependent and prostaglandin-independent pathways. In this report we demonstrate that epidermal growth factor and recombinant human transforming growth factor-alpha induce a significant rise in plasma calcium concentration when administered repeatedly to intact mice for periods ranging from 24 h to 16 d. The elevation of plasma calcium is not dependent on dietary calcium and is not invariably accompanied by an increase in systemic levels of the prostaglandin E2 metabolite 13,14-dihydro-15-keto-prostaglandin E2. The in vivo calcium-mobilizing activity of epidermal growth factor and transforming growth factor-alpha indicate that these or related growth factors need be considered as potential mediators of tumor-induced hypercalcemia.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3490496      PMCID: PMC423847          DOI: 10.1172/JCI112728

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

1.  Prostaglandin-mediated hypercalcemia in the VX2 carcinoma-bearing rabbit.

Authors:  H W Seyberth; W C Hubbard; O Oelz; B J Sweetman; J T Watson; J A Oates
Journal:  Prostaglandins       Date:  1977-08

2.  The multiple causes of hypercalcemia in malignant disease.

Authors:  L M Sherwood
Journal:  N Engl J Med       Date:  1980-12-11       Impact factor: 91.245

3.  Plasma prostaglandin levels in rats with diabetes mellitus and diabetic ketoacidosis.

Authors:  L Axelrod; L Levine
Journal:  Diabetes       Date:  1982-11       Impact factor: 9.461

4.  Dietary menhaden oil lowers plasma prostaglandins and calcium in mice bearing the prostaglandin-producing HSDM1 fibrosarcoma.

Authors:  A H Tashjian; E F Voelkel; D R Robinson; L Levine
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

5.  Human renal carcinoma cells produce hypercalcemia in the nude mouse and a novel protein recognized by parathyroid hormone receptors.

Authors:  G J Strewler; R D Williams; R A Nissenson
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

6.  Alpha and beta human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria.

Authors:  A H Tashjian; E F Voelkel; M Lazzaro; F R Singer; A B Roberts; R Derynck; M E Winkler; L Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

7.  Platelet-derived growth factor stimulates bone resorption via a prostaglandin-mediated mechanism.

Authors:  A H Tashjian; E L Hohmann; H N Antoniades; L Levine
Journal:  Endocrinology       Date:  1982-07       Impact factor: 4.736

8.  Epidermal growth factor causes hypocalcemia in sheep.

Authors:  G P Moore; M Wilkinson; B A Panaretto; L W Delbridge; S Posen
Journal:  Endocrinology       Date:  1986-04       Impact factor: 4.736

9.  Chemical instability of 15-keto-13,14-dihydro-PGE2: the reason for low assay reliability.

Authors:  E Granström; M Hamberg; G Hansson; H Kindahl
Journal:  Prostaglandins       Date:  1980-06

10.  Analysis by high performance liquid chromatography of cyclooxygenase products of arachidonic acid metabolism in plasma of rabbits bearing the VX2 carcinoma.

Authors:  I Alam; E F Voelkel; A H Tashjian; L Levine
Journal:  Prostaglandins Med       Date:  1980-04
View more
  18 in total

1.  Expression of epidermal growth factor and transforming growth factor alpha in interfacial membranes retrieved at revision total hip arthroplasty.

Authors:  J W Xu; J Ma; T F Li; E Waris; A Alberty; S Santavirta; Y T Konttinen
Journal:  Ann Rheum Dis       Date:  2000-10       Impact factor: 19.103

Review 2.  Incidence and pathophysiology of hypercalcemia.

Authors:  G R Mundy
Journal:  Calcif Tissue Int       Date:  1990       Impact factor: 4.333

3.  Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.

Authors:  J K Lee; M J Chuang; C C Lu; L J Hao; C Y Yang; T M Han; H C Lam
Journal:  J Endocrinol Invest       Date:  1997 Jul-Aug       Impact factor: 4.256

Review 4.  Hypercalcemia of malignancy revisited.

Authors:  G R Mundy
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

5.  Shifts in the concentrations of magnesium and calcium in early porcine and rat wound fluids activate the cell migratory response.

Authors:  J J Grzesiak; M D Pierschbacher
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

6.  Evidence for glomerular actions of epidermal growth factor in the rat.

Authors:  R C Harris; R L Hoover; H R Jacobson; K F Badr
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

Review 7.  Hypercalcaemia of malignancy.

Authors:  P J Kelly; J A Eisman
Journal:  Cancer Metastasis Rev       Date:  1989-06       Impact factor: 9.264

8.  Hemodynamic effects of epidermal growth factor in conscious rats and monkeys.

Authors:  J A Keiser; M J Ryan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

Review 9.  Hypercalcemia in malignancy.

Authors:  G J Strewler; R A Nissenson
Journal:  West J Med       Date:  1990-12

10.  Persistent expression of mitogenic/transforming factors at the site of failed orthopaedic implants: the impact on immune reactivity.

Authors:  J Bainbridge; N Al-Saffar
Journal:  J Mater Sci Mater Med       Date:  1998-12       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.